← FDA Drug Approvals (Drugs@FDA)

RAMELTEON

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANDAS 5 HOLDING · Approved 2022-08-24

Drug application

FDA Application #

ANDA215435

Application type

Abbreviated New Drug Application (Generic)

Brand name

RAMELTEON

Generic name

RAMELTEON

Active ingredients

RAMELTEON

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ANDAS 5 HOLDING

Manufacturer

Kanchan Healthcare Inc

First approval

2022-08-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown